CO65 Modelled Impact of Nirsevimab for All Infants in the Prevention of Respiratory Syncytial Virus (RSV): Related Hospitalizations and Its Predicted Cost to the Brazilian Public Healthcare System
| Autor: | Falavigna, M., Watanabe, S.F., Santoro, J., Ribeiro, K., Tolardo, A., Schneider, N., Safadi, M., Stein, R.T., Kieffer, A. |
|---|---|
| Zdroj: | In Value in Health December 2023 26(12) Supplement:S26-S26 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect